You have full access to this article via your institution.
Hello Nature readers, would you like to get this Briefing in your inbox free every day? Sign up here.
Getting roughly 6–8 hours of sleep each day has been linked with a longer life — at least in humans.Credit: Justin Paget/Getty
Getting about six to eight hours of sleep each day is linked to a lower risk of death and disease — any more or less is associated with accelerated biological ageing. Researchers analysed health data from more than 500,000 people and found that the ticks of 12 biological ‘clocks’ were generally slowest in people who got about seven hours of sleep, though the optimum amount of sleep time varied slightly between clocks that indicate age in different organs, and between men and women.
Ancient proteins extracted from the teeth of Homo erectus individuals that lived in China suggest that the group might have interbred with Denisovans, another archaic human species. Researchers used enamel proteins from six H. erectus individuals and identified an amino-acid variant that’s previously been seen in Denisovans. The group also identified two amino-acid sequence variants shared by all six individuals that set H. erectus apart from humans and other human relatives — something that has proved hard to find in the past.
For the first time, an antiviral pill has been shown to prevent people coming down with COVID-19 after being exposed to the SARS-CoV-2 virus. The drug, ensitrelvir, blocks an enzyme that coronaviruses need to make new copies of themselves. The results come years after the peak of the COVID-19 pandemic, but the drug could be a lifeline for those who still face real danger from the virus, such as care-home residents or transplant recipients on immune-suppressing medication.
Reference: New England Journal of Medicine paper
Features & opinion
India’s biggest gene-sequencing effort has shed new light on the diversity of the population, identifying nearly 130 million genetic variants, almost one-third of which have not been reported previously. The GenomeIndia project analysed the whole genomes of almost 10,000 people, uncovering 44 million variants that weren’t already in global scientific databases. The study also revealed genetic risk factors in some populations, such as variants in genes that affect how the body processes certain drugs, variants linked to anaesthesia-related complications and extremely high levels of genetic homozygosity — when individuals inherit identical forms of a gene at a particular chromosome location from both parents. This can be a risk factor for recessive genetic diseases.
Reference: medRxiv preprint (not peer reviewed)
Tim Bovard is the last full-time taxidermist at any museum in the United States. He maintains the animal mounts at the Museum of Natural History in Los Angeles, some of which have been in the museum’s collection for more than a century. A life-long animal enthusiast, Bovard is still dedicated to his craft after more than four decades at the museum, often sleeping in his office to cut out his commute. “It wouldn’t be for everybody,” Bovard says. “But I am known to be slightly different. That’s putting it sort of mildly.”
The New York Times | 5 min read
The physical appearance of antibiotic drugs is contributing to the rise of antimicrobial resistance, argues medical microbiologist Heiman Wertheim. If people can’t easily distinguish antibiotics from other medications, they won’t use them with care. And it isn’t just a problem among people prescribed the drugs: “I’ve asked audiences of infectious-disease specialists, who you’d assume would know, to identify an antibiotic in a photograph of three capsules,” he says. “Most of them pick the green and yellow one, which is actually a painkiller.”
This article is part of Nature Outlook: Antimicrobial resistance, an editorially-independent supplement produced with financial support from Meiji Seika Pharma.
Infographic of the week
Figure 1 | Gut changes that aid immune defences during and after pregnancy. Huang et al. report that immune cells influence changes to gut tissue in mice. a, In mice that have not become pregnant, harmful bacteria in the gut can cross epithelial cells that line the intestine and invade inner gut tissue in which they might encounter immune cells. b, In pregnant mice, the authors report that immune cells called eosinophils help to boost the number of mucus-producing goblet cells that line the gut. This change results in a thick layer of mucus, which limits the ability of harmful bacteria to invade the gut. The protection persists when the animals are breastfeeding.
Being pregnant, or breastfeeding, seems to cause immune changes that bolster the gut’s defence against harmful bacteria. In mice, immune cells called eosinophils boost the number of goblet cells in the gut lining, which produce a thick mucus that shuts out invading bacteria. (Nature News & Views | 8 min read)
Today I’m wondering which of our Solar System’s planets I would want my child to share a name with. My pick is Jupiter — my favourite of the planets since childhood (just because I think it’s cool). But according to the US Social Security Administration, Mars came out on top in the United States in 2025, with 132 children given the red planet’s name.
Only one planet didn’t make the list (I’ll let you work out which).
Send me your pick of the planets, along with any feedback on this newsletter, at [email protected].
Thanks for reading,
Jacob Smith, associate editor, Nature Briefing
With contributions by Flora Graham
• Nature Briefing: Careers — insights, advice and award-winning journalism to help you optimize your working life
• Nature Briefing: Microbiology — the most abundant living entities on our planet — microorganisms — and the role they play in health, the environment and food systems
• Nature Briefing: Anthropocene — climate change, biodiversity, sustainability and geoengineering
• Nature Briefing: AI & Robotics — 100% written by humans, of course
• Nature Briefing: Cancer — a weekly newsletter written with cancer researchers in mind
• Nature Briefing: Translational Research — covers biotechnology, drug discovery and pharma
